Please sign in to follow a disease.

Tumor necrosis factor-alpha

Clinical trials for Tumor necrosis factor-alpha explained in plain language.

Never miss a new study

Get alerted when new Tumor necrosis factor-alpha trials appear

Sign up with your email to follow new studies for Tumor necrosis factor-alpha, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

Could an arthritis drug shrink dangerous brain aneurysms?

Disease control Recruiting now

This study tests whether infliximab (Remicade), a drug used for arthritis and other inflammatory conditions, can shrink a specific type of brain aneurysm called a dolichoectactic vertebrobasilar (DVB) aneurysm. These aneurysms are difficult to treat with surgery or stents, and th…

Matched conditions: TUMOR NECROSIS FACTOR-ALPHA

Phase 1/2 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

Tumor necrosis factor-alpha

Get alerted when new Tumor necrosis factor-alpha trials appear

Could an arthritis drug shrink dangerous brain aneurysms?